+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

  • PDF Icon

    Report

  • 276 Pages
  • November 2022
  • Region: Global
  • The Business Research Company
  • ID: 5684019
This report describes and explains the induced pluripotent stem cell (iPSC) market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The global induced pluripotent stem cell (iPSC) market reached a value of nearly $2,431.2 million in 2021, having increased at a compound annual growth rate (CAGR) of 10.8% since 2016. The market is expected to grow from $2,431.2 million in 2021 to $3,997.5 million in 2026 at a rate of 10.5%. The market is then expected to grow at a CAGR of 9.2% from 2026 and reach $6,195.8 million in 2031.

Growth in the historic period resulted from increased healthcare expenditure, a rise in funding, the development of non-animal alternatives for preclinical drug research, reduced cost for drug discovery and increasing demand for personalized medicine. Factors that negatively affected growth in the historic period were the lack of awareness on induced pluripotent stem cells and inadequate reimbursements.

Going forward, increasing prevalence of chronic diseases, growth in genomic projects, development of iPSC-derived disease models, increasing funding and increasing prevalence of genetic diseases will drive market growth. Factors that could hinder the growth of the induced pluripotent stem cell (iPSC) market in the future include automation of iPSC production, the risk associated with induced pluripotent stem cell treatment, high cost associated with storage, low per capita healthcare expenditure and disruption of medical facilities due to Russia-Ukraine war and the coronavirus pandemic.

The induced pluripotent stem cell (iPSC) market is segmented by derived cell type into hepatocytes, fibroblasts, keratinocytes, amniotic cells, and others. The fibroblasts was the largest segment of the induced pluripotent stem cell (iPSC) market by type, accounting for $728.0 million or 29.9% of the total market in 2021. The others market is expected to be the fastest-growing segment going forward at a CAGR of 12.3%.

The induced pluripotent stem cell (iPSC) market is segmented by application into academic research, drug discovery and toxicity studies, regenerative medicine and cell & gene therapy. The drug discovery and toxicity studies was the largest segment of the induced pluripotent stem cell (iPSC) market by application, accounting for $1,178.3 million or 48.5% of the total market in 2021. The cell & gene therapy market is expected to be the fastest-growing segment going forward at a CAGR of 12.0%.

The induced pluripotent stem cell (iPSC) market is segmented by end-users into hospitals, and research laboratories. The research laboratories market was the largest segment of the induced pluripotent stem cell (iPSC) market by end user, accounting for $1,658.7 million or 68.2% of the total market in 2021. The hospitals market is expected to be the fastest-growing segment going forward at a CAGR of 11.3%.

North America was the largest region in the induced pluripotent stem cell (iPSC) market, accounting for 48.9% of the global market in 2021. It was followed by Western Europe, Asia Pacific and the other regions. Going forward, the fastest growing regions in the induced pluripotent stem cell (iPSC) market will be South America and the Middle East, where growth will be at CAGRs of 35.1% and 33.5% respectively from 2021-2026.

The induced pluripotent stem cell (iPSC) market is highly fragmented, with a large number of players. The top ten competitors in the market made up to 27.50% of the total market in 2021. This is mainly due to the high growth potential of the market that is attracting the new players. FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc) was the largest competitor with 10.46% share of the market, followed by Thermo Fisher Scientific, Inc with 6.43%, Takara Bio, Inc with 3.78%, Lonza Group AG with 2.81%, Astellas Pharma Inc with 1.51%, ViaCyte, Inc with 0.90%, Ncardia with 0.70%, REPROCELL USA, Inc with 0.62%, Japan Tissue Engineering Co., Ltd with 0.24%, and Merck KGaA with 0.05%.

The top opportunities in the induced pluripotent stem cell (iPSC) market by derived cell type will arise in the fibroblasts market, which will gain $456.5 million of global annual sales by 2026. The top opportunities in the induced pluripotent stem cell (iPSC) market by application will arise in the drug discovery & toxicity studies market, which will gain $710.9 million of global annual sales by 2026. The top opportunities in the induced pluripotent stem cell (iPSC) market by end-user will arise in the research laboratories market, which will gain $1,018.1 million of global annual sales by 2026. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $253.7 million.

Market-trend-based strategies for the induced pluripotent stem cell (iPSC) market include investing in iPSC’s for treating Parkinson’s disease, focusing on strategic collaborations, investing in developing of iPSC-derived NK cells, focus on research and development, focus on investment in regenerative medicine, focus on advancements in technology transfer and clinical translation and focus on solutions for treating diabetes.

Player-adopted strategies in the induced pluripotent stem cell (iPSC) market include focus on expanding operational capabilities, focus on new product launches, focus on strategic agreements and focus on strategic collaborations and partnerships.

To take advantage of the opportunities, the publisher recommends the induced pluripotent stem cell (iPSC) companies to focus on pluripotent stem cells for treating Parkinson’s disease, focus on development of induced pluripotent stem cell (iPSC)-derived NK cells, focus on induced pluripotent stem cell (iPSC) for cell therapy, focus on use of pluripotent stem cells in treating type 1 diabetes, expand in emerging economies, continue to focus on developed markets, focus on strategic partnerships and collaborations, offer competitive prices, continue to use B2B promotions, continue to participate in events and conferences and target fast-growing applications.

Frequently Asked Questions about the Global Induced Pluripotent Stem Cell (iPSC) Market

What is the estimated value of the Global Induced Pluripotent Stem Cell (iPSC) Market?

The Global Induced Pluripotent Stem Cell (iPSC) Market was estimated to be valued at $2431.2 Million in 2021.

What is the growth rate of the Global Induced Pluripotent Stem Cell (iPSC) Market?

The growth rate of the Global Induced Pluripotent Stem Cell (iPSC) Market is 9.8%, with an estimated value of $6195.8 Million by 2031.

What is the forecasted size of the Global Induced Pluripotent Stem Cell (iPSC) Market?

The Global Induced Pluripotent Stem Cell (iPSC) Market is estimated to be worth $6195.8 Million by 2031.

Who are the key companies in the Global Induced Pluripotent Stem Cell (iPSC) Market?

Key companies in the Global Induced Pluripotent Stem Cell (iPSC) Market include FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc.), Thermo Fisher Scientific, Inc., Takara Bio, Inc. and Astellas Pharma Inc..

Table of Contents

1. Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Induced Pluripotent Stem Cell (iPSC) Market Definition and Segmentations
6.4. Market Segmentation By Derived Cell Type
6.4.1. Blood Cells
6.4.2. Hepatocytes
6.4.3. Fibroblasts
6.4.4. Keratinocytes
6.4.5. Amniotic
6.4.6. Others
6.5. Market Segmentation By Application
6.5.1. Academic Research
6.5.2. Drug Discovery And Toxicity Studies
6.5.3. Regenerative Medicine
6.5.4. Gene & Cell Therapy
6.6. Market Segmentation By End-User
6.6.1. Hospitals
6.6.2. Research Laboratories
7. Major Market Trends
7.1. Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)
7.2. Strategic Collaborations And Partnerships
7.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells
7.4. Demand For Induced Pluripotent Stem Cell (iPSC) For Cell Therapy
7.5. Investment In Regenerative Medicine Research And Development
7.6. Advancements In Technology Transfer And Clinical Translation
7.7. Use of Pluripotent Stem Cells in treating Type 1 Diabetes
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
8.2.1. Market Drivers 2016 - 2021
8.2.2. Market Restraints 2016 - 2021
8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 - 2026
8.3.2. Market Restraints 2021 - 2026
9. Global Market Segmentation
9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
11.8. China Market
11.9. Summary
11.10. Market Overview
11.10.1. Country Information
11.10.2. Market Information
11.10.3. Background Information
11.10.4. Government Initiatives
11.10.5. Regulations
11.10.6. Regulatory Bodies
11.10.7. Major Associations
11.10.8. Taxes Levied
11.10.9. Corporate Tax Structure
11.10.10. Investments
11.10.11. Major Companies
11.11. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.12. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.13. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.14. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.15. India Market
11.16. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.17. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.18. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.19. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.20. Japan Market
11.21. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.22. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.23. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.24. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.25. Australia Market
11.26. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.27. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.28. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.30. Indonesia Market
11.31. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.32. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.33. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.34. South Korea Market
11.35. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.36. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.37. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.38. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
12.8. UK Market
12.9. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.12. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.13. Germany Market
12.14. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.15. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.17. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.18. France Market
12.19. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.20. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.21. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.22. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes levied
13.2.9. Corporate tax structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
13.8. Russia Market
13.9. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.12. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes levied
14.2.9. Corporate tax structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
14.8. USA Market
14.9. Summary
14.10. Market Overview
14.10.1. Country Information
14.10.2. Market Information
14.10.3. Background Information
14.10.4. Government Initiatives
14.10.5. Regulations
14.10.6. Regulatory Bodies
14.10.7. Associations
14.10.8. Taxes Levied
14.10.9. Corporate Tax Structure
14.10.10. Investments
14.10.11. Major Companies
14.11. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.13. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.14. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
15.8. Brazil Market
15.9. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.12. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory bodies
16.2.7. Major Associations
16.2.8. Taxes levied
16.2.9. Corporate tax structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory bodies
17.2.7. Major Associations
17.2.8. Taxes levied
17.2.9. Corporate tax structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.5. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
19. Company Profiles
19.1. FUJIFILM Holdings Corporation
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Thermo Fisher Scientific, Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Takara Bio, Inc
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Lonza Group AG
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Astellas Pharma Inc
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Key Mergers and Acquisitions
20.1. Vertex Pharmaceuticals Acquired ViaCyte
20.2. Medipost Acquired OmniaBio
20.3. Catalent Acquired RheinCell Therapeutics
20.4. Selvita Acquired Fidelta from Galapagos
20.5. Bayer Acquired Asklepios BioPharmaceutical (AskBio)
20.6. Boehringer Ingelheim Acquired Global Stem Cell Technology (GST)
20.7. Vertex Pharmaceuticals Acquired Semma Therapeutics
21. Opportunities And Strategies
21.1. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 - Countries Offering Most New Opportunities
21.2. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 - Segments Offering Most New Opportunities
21.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 - Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Biotechnology Services Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. About the Publisher
23.5. Copyright and Disclaimer

Executive Summary

Induced Pluripotent Stem Cell (IPSC) Global Market Opportunities And Strategies To 2031 from the publisher provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest growing market for induced pluripotent stem cell (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cell (iPSC) market global report from the publisher answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider induced pluripotent stem cell (iPSC) market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the induced pluripotent stem cell (iPSC) market
  • Key Trends - Highlights the major trends shaping the global induced pluripotent stem cell (iPSC) market. This section also highlights likely future developments in the market
  • Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods
  • Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country
  • Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by derived cell type, by application, and by end-user in the market
  • Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets
  • Conclusions And Recommendations - Includes recommendations for induced pluripotent stem cell (IPSC) providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups
  • Appendix
  • This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Scope

Markets Covered:

  • 1) By Derived Cell Type: Blood Cells; Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
  • 2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell & Gene Therapy
  • 3) By End-User: Hospitals; Research Laboratories
Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc.); Thermo Fisher Scientific, Inc.; Takara Bio, Inc.; Lonza Group AG; Astellas Pharma Inc.

Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cell (iPSC) indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc.)
  • Thermo Fisher Scientific, Inc.
  • Takara Bio, Inc.
  • Lonza Group AG
  • Astellas Pharma Inc.

Methodology

Loading
LOADING...